Dr. Subeer K. Wadia, MD

Dr. Wadia practices at UChicago Medicine AdventHealth Bolingbrook in Bolingbrook, Illinois, part of The University of Chicago.

Dr. Wadia's NPI, 1578900999, was assigned on May 24, 2013. Dr. Wadia graduated from Saint Louis University School Of Medicine in 2013. Dr. Wadia's California license number on file is A139639.

Dr. Wadia's primary practice is UChicago Medicine AdventHealth Bolingbrook, at 500 Remington Boulevard, Bolingbrook, IL 60440 in Will County. The practice phone is (630) 312-5000.

Dr. Wadia's primary practice is UChicago Medicine AdventHealth Bolingbrook in Bolingbrook, Illinois, part of The University of Chicago. Dr. Wadia is also affiliated with UChicago Medicine AdventHealth Hinsdale. The medical group on file is UChicago Medicine AdventHealth Medical Group. Dmand AI also links Dr. Wadia to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wadia practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Wadia's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Wadia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Wadia's licenses on file in 5 states: California, Ohio, Indiana, Washington and Illinois.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Wadia treats.

CMS data shows 2,074 Medicare services from Dr. Wadia across 35 procedure codes in 2023, for 11 Medicare patients. Medicare paid $331,184 for them.

CMS counts 11 Medicare patients who saw Dr. Wadia in 2024. The largest group is 75 to 84, with 0 patients. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wadia's median patient age at 71, with 54% women.

In 2024, Dr. Wadia wrote 382 Medicare Part D claims for 140 patients. 79% of them were for generic drugs. CMS names the drug for 242 of them, across 14 drugs with 11 or more claims each, at $56,547 in total drug cost. In 2023, CMS named 1,804 claims across 34 drugs.

Dr. Wadia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wadia as offering telehealth. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Wadia, more than 58% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Wadia, published from 2016 to 2020. 2016 was the busiest year, with 3. Dr. Wadia's most frequent co-authors are Jamil Anis Aboulhosn, MD, Gentian Lluri and Morris Salem, MD.

CMS Open Payments shows 196 general payments to Dr. Wadia from 34 drug and device companies from 2018 to 2025. Grants make up the largest share, 69% of the total. Medtronic Vascular, Inc. paid the most, $15,289.

Dr. Wadia graduated from Saint Louis University School Of Medicine in 2013.

Dr. Wadia is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Molina. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.